The Centers for Medicare & Medicaid Services today added 12 new ICD-10 procedure codes to identify new therapies for COVID-19.

These include remdesivir and convalescent plasma, as well as any future COVID-19 therapeutic that does not have a unique name.

CMS also released a new ICD-10 Medicare Severity-Diagnosis Related Group Grouper software package (Version 37.2) to accommodate the new codes, effective for discharges on or after Aug. 1. 

The new codes will not affect the MS-DRG assignment.

Related News Articles

#HealthCareInnovation Thursday Blog
Early on in my professional journey as a physician, I had a calling to work with infectious diseases. Little did I know then how big a role this medical…
Headline
On Dec. 15, the Department of Health and Human Services will stop collecting hospitals’ COVID-19 data through the TeleTracking portal and begin collecting the…
Headline
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., today encouraged all eligible Americans to get vaccinated against the flu and…
Headline
The Food and Drug Administration does not currently authorize the monoclonal antibody bamlanivimab for emergency use to treat mild-to-moderate COVID-19 in the…
Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…
Headline
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine. In addition to ongoing pop-up clinics,…